Provided by Tiger Fintech (Singapore) Pte. Ltd.

SILO PHARMA INC.

0.6663
+0.00590.89%
Post-market: 0.6600-0.0063-0.95%19:46 EDT
Volume:199.74K
Turnover:133.08K
Market Cap:4.80M
PE:-0.59
High:0.6840
Open:0.6745
Low:0.6600
Close:0.6604
Loading ...

Silo Pharma files patent application with USPTO for SPC-14

TIPRANKS
·
28 Apr

Psychedelic: Clearmind completes clinical site initiations for AUD trial

TipRanks
·
25 Apr

Saucony® Unveils Saucony SILO: A New Pinnacle in Luxury Footwear

PR Newswire
·
17 Apr

Silo Pharma announces first dosing in IND-enabling study for SPC-15

TIPRANKS
·
26 Mar

BRIEF-Silo Pharma Achieves Key Milestone With First Dosing In IND-Enabling GLP Study For SPC-15 As A Groundbreaking PTSD Treatment

Reuters
·
26 Mar

Silo Pharma Achieves Key Milestone with First Dosing in IND-Enabling GLP Study for SPC-15 as a Groundbreaking PTSD Treatment

GlobeNewswire
·
26 Mar

Psychedelic: Exclusive talk with biotech company Clearmind Medicine

TipRanks
·
22 Mar

Psychedelic: atai reports dosing of first patient in Phase 2 VLS-01 trial

TipRanks
·
14 Mar

Silo Pharma Granted US Patent for Intranasal Post-Traumatic Stress Disorder Treatment

MT Newswires Live
·
27 Feb

BRIEF-Silo Pharma Expands Intellectual Property Portfolio With Provisional Patent Filing For Innovative SPC-15 Combination Treatment

Reuters
·
18 Feb

Silo Pharma files provisional patent for SPC-15 combination

TIPRANKS
·
18 Feb

Silo Pharma Expands Intellectual Property Portfolio with Provisional Patent Filing for Innovative SPC-15 Combination Treatment

GlobeNewswire
·
18 Feb

BRIEF-Silo Pharma Announces Positive Initial Pharmacokinetic, Safety, And Tolerability Study Of SP-26 For Chronic Pain And Fibromyalgia

Reuters
·
11 Feb

LIBERTY LATIN AMERICA’S C&W CREDIT SILO COMPLETES REFINANCING PROGRAM; ISSUES NEW $755 MILLION SENIOR NOTES DUE 2033

Business Wire
·
11 Feb

LIBERTY LATIN AMERICA’S C&W CREDIT SILO PRICES NEW $1.5 BILLION TERM LOAN DUE 2032

Business Wire
·
05 Feb